Related Experiment Videos
Ketorolac after congenital heart surgery: does it increase the risk of significant bleeding complications?
Anuja Gupta1, Casey Daggett, Joseph Ludwick
1Childrens Hospital Los Angeles, University of Southern California, Los Angeles, CA, USA. doctoranuja@yahoo.com
Insights
Ketorolac use after pediatric congenital heart surgery did not increase bleeding risk requiring surgical intervention. This study suggests ketorolac is safe for managing pain in these young patients.
Area of Science:
- Pediatric Cardiac Surgery
- Pharmacology
- Postoperative Care
Background:
- Concerns exist regarding ketorolac's potential for bleeding complications in pediatric cardiac surgery.
- This study addresses the safety of routine ketorolac use in this vulnerable population.
Purpose of the Study:
- To evaluate the association between postoperative ketorolac administration and significant bleeding requiring surgical exploration in infants and children undergoing congenital heart surgery.
Main Methods:
- Retrospective chart review of 842 pediatric patients undergoing congenital heart surgery.
- Comparison of 94 patients receiving postoperative ketorolac with 94 matched controls not receiving ketorolac.
- Outcome measured: postoperative bleeding necessitating surgical exploration.
Main Results:
- No patients (0%) in the ketorolac group required surgical exploration for bleeding, compared to 4.2% in the non-ketorolac group.
- The relative risk for bleeding requiring surgical exploration was 0.2 (95% CI 0.02-1.67) for the ketorolac group.
- Ketorolac was administered to 11.1% of the study cohort.
Conclusions:
- Postoperative ketorolac administration in infants and children following congenital heart surgery is not associated with a significant increase in bleeding complications requiring surgical intervention.
- Findings support the judicious use of ketorolac for pain management in this patient population.
Background:
The routine use of ketorolac after congenital heart surgery in infants and children is limited by concerns for postoperative bleeding complications. The object of this study was to determine if the use of ketorolac is associated with an increased risk of significant postoperative bleeding after congenital heart surgery in infants and children.
Methods:
A retrospective chart review was performed. The exposure of interest was postoperative use of ketorolac after congenital heart surgery in infants and children. The outcome measured was postoperative bleeding requiring surgical exploration. The patients who received ketorolac were compared with an age- and diagnosis-matched comparison group who did not receive ketorolac.
Results:
Records of 842 infants and children who underwent congenital heart surgery between July 2001 and October 2002 were reviewed. 94 (11.1%) patients were treated with ketorolac postoperatively. The comparison group consisted of 94 matched subjects selected from the patients that did not receive ketorolac. The mean age of patient in the ketorolac group was 8.5 (+/-6.1) years. No (0%) patients in the ketorolac group and four (4.2%) patients in the nonketorolac group developed postoperative bleeding requiring surgical exploration. The relative risk for postoperative bleeding that required surgical exploration in the ketorolac group compared with the nonketorolac group was 0.2 (95% CI 0.02-1.67).
Conclusions:
The use of ketorolac after congenital heart surgery in infants and children does not significantly increase the risk of bleeding complications requiring surgical exploration.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Aneurysm IV: Nursing Management
Kidney Transplant II: Surgical Procedure
Cardiac Catheterization I: Pre-Procedure Overview
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...